[Federal Register Volume 67, Number 98 (Tuesday, May 21, 2002)]
[Notices]
[Pages 35822-35823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Prospective Grant of Exclusive License: Control of Arthropod 
Vectors of Parasitic Diseases

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7 (a) (1) (i) that the Centers for Disease Control and 
Prevention (CDC), Technology Transfer Office, Department of Health and 
Human Services (DHHS), is contemplating the grant of a worldwide 
exclusive license to practice the inventions embodied in the patent 
application referred to below to Aventis Environmental Sciences, a 
business unit of Aventis CropScience, of Montvale, New Jersey. The 
patent rights in these inventions have been assigned to the government 
of the United States of America. The patent application to be licensed 
is:
    Title: Use of Fipronil to Control Ixodes Ticks and Control Lyme 
Disease. U.S. Patent Application Serial No. 09/595,035 Filing Date: 06/
16/00
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

[[Page 35823]]

    This invention comprises a method of controlling Lyme disease by 
preventing the maturation of deer ticks on white-footed mice by 
exposing the mice to fipronil as they enter food-baited boxes.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments, and other materials relating to the contemplated license 
should be directed to Andrew Watkins, Director, Technology Transfer 
Office, Centers for Disease Control and Prevention (CDC), 4770 Buford 
Highway, Mailstop K-79, Atlanta, GA 30341, telephone: (770) 
488-8600; facsimile: (770) 488-8615. Applications for a 
license filed in response to this notice will be treated as objections 
to the grant of the contemplated license. Only written comments and/or 
applications for a license which are received by CDC within fifteen 
days of this notice will be considered.
    Comments and objections submitted in response to this notice will 
not be made available for public inspection, and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act, 5 U.S.C. 552. A signed Confidential Disclosure Agreement will be 
required to receive a copy of any pending patent application.

    Dated: May 15, 2002.
James D. Seligman,
Associate Director for Program Services, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 02-12649 Filed 5-20-02; 8:45 am]
BILLING CODE 4163-18-P